We represented a significant product liability matter involving a dietary supplement that was released into the stream of commerce as a defective product by a manufacturing company that subcontracted the actual manufacture of the substance without permission from the health care company. Through our position statement, we argued the that dietary supplement was not adequate and that it was manufactured in an inferior manner whereby it was then placed into the stream of commerce without adequate safety testing, thereof. Thus, we established that the defendant failed to manufacture the supplement within the proper scientific specifications, thereof.
Case Settled in Southern District Court of the State of New York
Thursday, December 8th, 2011